Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma

Magnetic Resonance Imaging

Volumn 32, Issue 6, 2014, Pages 630-637

  Chen, YunBin ^a   Liu, Xiangyi ^a   Zheng, Dechun ^a   Xu, Luying ^a   Hong, Liang ^a   Xu, Yun ^a   Pan, Jianji ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Chemoradiotherapy; Diffusion weighted MRI; Nasopharyngeal carcinoma; Treatment assessment

Indexed keywords

CETUXIMAB; CISPLATIN; GEMCITABINE;

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CHEMORADIOTHERAPY; CLINICAL ARTICLE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEASIBILITY STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME; ADOLESCENT; CANCER STAGING; NASOPHARYNGEAL NEOPLASMS; PATHOLOGY; PROCEDURES;

ADOLESCENT; ADULT; AGED; CHEMORADIOTHERAPY; DIFFUSION MAGNETIC RESONANCE IMAGING; FEASIBILITY STUDIES; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84900988688     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2014.02.009     Document Type: Article

References (39)

1. Lee A.W., Lin J.C., Ng W.T. Current management of nasopharyngeal cancer. Semin Radiat Oncol 2012, 22(3):233-244.
2. Tham I.W., Hee S.W., Yeo R.M., et al. Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre Singapore experience. Int J Radiat Oncol Biol Phys 2009, 75(5):1481-1486.
3. Geara F.B., Sanguineti G., Tucker S.L., et al. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival. Radiother Oncol 1997, 43(1):53-61.
4. Perez C.A., Devineni V.R., Marcial-Vega V., Marks J.E., Simpson J.R., Kucik N. Carcinoma of the nasopharynx: factors affecting prognosis. Int J Radiat Oncol Biol Phys 1992, 23(2):271-280.
5. Liu H., Chen Q.Y., Guo L., et al. Feasibility and efficacy of chemoradiotherapy for elderly patients with locoregionally advanced nasopharyngeal carcinoma: results from a matched cohort analysis. Radiat Oncol 2013, 8(1):70.
6. Ji X., Xie C., Hu D., Fan X., Zhou Y., Zheng Y. Survival benefit of adding chemotherapy to intensity modulated radiation in patients with locoregionally advanced nasopharyngeal carcinoma. PLoS One 2013, 8(2):e56208.
7. Lee A.W., Tung S.Y., Chua D.T., et al. Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 2010, 102(15):1188-1198.
8. Ponzanelli A., Vigo V., Marcenaro M., et al. Induction chemotherapy followed by alternating chemo-radiotherapy in non-endemic undifferentiated carcinoma of the nasopharynx: optimal compliance and promising 4-year results. Oral Oncol 2008, 44(8):767-774.
9. Chen Y., Liu M.Z., Liang S.B., et al. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of China. Int J Radiat Oncol Biol Phys 2008, 71(5):1356-1364.
10. Roe K., Kakar M., Seierstad T., Ree A.H., Olsen D.R. Early prediction of response to radiotherapy and androgen-deprivation therapy in prostate cancer by repeated functional MRI: a preclinical study. Radiat Oncol 2011, 6:65.
11. Park S.H., Moon W.K., Cho N., et al. Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Radiology 2010, 257(1):56-63.
12. Mabanta S.R., Mendenhall W.M., Stringer S.P., Cassisi N.J. Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes. Neck Surg 1999, 21(7):591-594.
13. Castaldi P., Leccisotti L., Bussu F., Micciche F., Rufini V. Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma. Acta Otorhinolaryngol Ital 2013, 33(1):1-8.
14. Hentschel M., Appold S., Schreiber A., et al. Serial FDG-PET on patients with head and neck cancer: implications for radiation therapy. Int J Radiat Biol 2009, 85(9):796-804.
15. Madani I., Duthoy W., Derie C., et al. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2007, 68(1):126-135.
16. Chenevert T.L., Meyer C.R., Moffat B.A., et al. Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. Mol Imaging 2002, 1(4):336-343.
17. Huang M.Q., Pickup S., Nelson D.S., et al. Monitoring response to chemotherapy of non-Hodgkin's lymphoma xenografts by T(2)-weighted and diffusion-weighted MRI. NMR Biomed 2008, 21(10):1021-1029.
18. Charles-Edwards E.M. deSouza NM. Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging 2006, 6:135-143.
19. Sharma U., Danishad K.K., Seenu V., Jagannathan N.R. Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed 2009, 22(1):104-113.
20. Kim S., Loevner L., Quon H., et al. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 2009, 15(3):986-994.
21. Hatakenaka M., Nakamura K., Yabuuchi H., et al. Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy. Int J Radiat Oncol Biol Phys 2011, 81:339-345.
22. Vandecaveye V., Dirix P., De Keyzer F., et al. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol 2010, 20(7):1703-1714.
23. Golden D.W., Rudra S., Witt M.E., et al. Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinoma. Oral Oncol 2013, 49(3):277-282.
24. Eisenhauer E.A., Therasse P., Bogaerts J., et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009, 45(2):228-247.
25. van den Brekel M.W., Stel H.V., Castelijns J.A., et al. Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 1990, 177(2):379-384.
26. Vandecaveye V., Dirix P., De Keyzer F., et al. Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2012, 82(3):1098-1107.
27. Galban C.J., Mukherji S.K., Chenevert T.L., et al. A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol 2009, 2(3):184-190.
28. Koh D.M., Scurr E., Collins D., et al. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR Am J Roentgenol 2007, 188(4):1001-1008.
29. Sugahara T., Korogi Y., Kochi M., et al. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 1999, 9(1):53-60.
30. Vandecaveye V., De Keyzer F., Hermans R. Diffusion-weighted magnetic resonance imaging in neck lymph adenopathy. Cancer Imaging 2008, 8:173-180.
31. Patterson D.M., Padhani A.R., Collins D.J. Technology insight: water diffusion MRI-a potential new biomarker of response to cancer therapy. Nat Clin Pract Oncol 2008, 5(4):220-233.
32. Vandecaveye V., De Keyzer F., Nuyts S., et al. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. International journal of radiation oncology, biology, physics 2007, 67(4):960-971.
33. Zips D., Eicheler W., Bruchner K., et al. Impact of the tumour bed effect on microenvironment, radiobiological hypoxia and the outcome of fractionated radiotherapy of human FaDu squamous-cell carcinoma growing in the nude mouse. Int J Radiat Biol 2001, 77(12):1185-1193.
34. Koh D.M., Collins D.J. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007, 188(6):1622-1635.
35. Yoshizako T., Wada A., Uchida K., et al. Apparent diffusion coefficient of line scan diffusion image in normal prostate and prostate cancer-comparison with single-shot echo planner image. Magn Reson Imaging 2011, 29(1):106-110.
36. Attenberger U.I., Runge V.M., Stemmer A., et al. Diffusion weighted imaging: a comprehensive evaluation of a fast spin echo DWI sequence with BLADE (PROPELLER) k-space sampling at 3T, using a 32-channel head coil in acute brain ischemia. Invest Radiol 2009, 44(10):656-661.
37. Varoquaux A., Rager O., Lovblad K.O., et al. Functional imaging of head and neck squamous cell carcinoma with diffusion-weighted MRI and FDG PET/CT: quantitative analysis of ADC and SUV. Eur J Nucl Med Mol Imaging 2013, 40(6):842-852.
38. Wu X., Jeong E.K., Emerson L., et al. Noninvasive evaluation of antiangiogenic effect in a mouse tumor model by DCE-MRI with Gd-DTPA cystamine copolymers[J]. Mol Pharm 2009, 7(1):41-48.
39. Kim S., Loevner L.A., Quon H., et al. Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2010, 31(2):262-268.